Figure 1.

Flow Chart of identification of eligible studies (last search conducted on 3.3.16). *Other reasons were abstracts without published full manuscripts (n=33), no original studies (25), no specific estimates on HIV/HCV-coinfection (33), less than 20 HIV-infected patients (16), insufficient information on HCV testing or study population (8), no reported estimates from the African continent (3), data based on a population with liver disease only (1), reported data on patients included in another study (5).